[On the role of GABA in anxiety and depression]
Abstract:
Data on the role of gamma-aminobutyric acid (GABA) in pathogenesis of anxiety and depression are critically assessed. Clinical and experimental results indicative of an important role of GABA as the neurotransmitter involved in these mental states and their integration within a common pathogenic process are considered. The general neurochemical, pharmacological, and neurophysiological aspects of anxiety and depression are analyzed in the context of GABAergic system involvement in this process and the possibility of using GABAergic agents for the therapy of various related disorders.
Related Concept Videos
G-protein Coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Generalized Anxiety Disorder


